Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel for Postsurgical Pain in Lower Extremity Fractures
NCT02214810Phase 2Withdrawn
- Sponsor
- Broward Health
- Start
- Jan 2015
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bupivacaine in Persistent postsurgical pain (PPSP), sponsored by Broward Health. Planned start Jan 2015; status: withdrawn.
02
Drugs
bupivacaine
03
Conditions
Persistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on NCT02214810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02214810.